Home / Market News / $CVRX
fiscal.ai Corporate Catalyst Impact 75/100 ● positive

CVRx Reports Third Quarter 2026 Financial and Operating Results

Nov 6, 2026, 2:24 PM UTC · Primary ticker $CVRX

CVRx reported Q3 2026 revenue of $13.8 million, with U.S. revenue at $13.0 million, and updated its full-year 2026 revenue guidance to $56.0-$57.0 million. The company also announced a new CFO, John Landry, effective November 6, 2026. This combination of financial results, revised outlook, and a key executive appointment suggests a significant operational update for investors.

CVRx reported its third-quarter 2026 financial results, showing $13.8 million in total revenue and $13.0 million from the U.S. The company also updated its full-year 2026 revenue guidance to a range of $56.0 million to $57.0 million. This guidance update is a key driver for short-term stock movement as it provides a revised outlook on future performance. Additionally, the appointment of a new Chief Financial Officer, John Landry, signals a change in leadership for a critical financial role, which can have long-term implications for financial strategy and investor relations. The growth in active implanting centers and progress in Medicare Advantage coverage are positive operational indicators, but the updated guidance will likely be the most immediate market mover. Traders should assess if the updated guidance meets, exceeds, or falls short of prior expectations and analyst consensus.

$CVRX neutral Primary subject of financial results and guidance update
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.